Answering the narrow version, because the broad one does not have a single answer. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.
I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
What I am after is how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
Practical detail welcome, however dull — the duller the better.
Dr.CardioMD said:The version of this that has an answer is narrower than the version being asked.
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDataDave said:I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
Can confirm. Same sequence, different timescale. I had assumed I was the exception until I read this.
Clinical perspective, offered as context rather than as advice. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.